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Objective In the past few decades, the study of skeletal muscle oxidative stress has been concerned 
about the increase of free radicals induced by muscle contraction. In recent years, the activation of 
antioxidant stress signaling pathway has gradually become one of the hot topics in the field of sports 
medicine. Although current research has confirmed that long-term aerobic training can bring health 
benefits to the body, the molecular mechanism of its role is still not very clear.Traditionally, AMPK 
has been regarded as the energy receptor of cells. During exercise, the energy consumption of 
skeletal muscle doubled, ATP decreased, AMP increased, and the ratio of AMP/ATP increased, thus 
inducing the activation of AMPK and regulating cell energy metabolism. Recent studies have found 
that AMPK not only plays an important role in the regulation of energy metabolism, but also plays a 
role in the body's antioxidant stress response. However, the relationship between AMPK and 
oxidative stress has been studied only in a small number of cells in non skeletal muscle cells. The 
results of this few studies show that oxidative stress in AMPK can not depend on the increase of 
intracellular AMP/ATP ratio, and the independent activation of AMPK, thus reducing the level of 
intracellular ROS, but the molecular mechanism of its action is not clear. Nrf2 is an important nuclear 
transcription factor in the body and plays an important role in the body's antioxidant stress 
response. Whether AMPK can participate in the regulation of Nrf2 mediated antioxidant activity in 
skeletal muscle has not been reported.In this study, the mouse skeletal muscle C2C12 cells were used 
in vitro cell experiments. The AMPK pharmacologic activator AICAR and the pharmacological 
inhibitor Compound C were used to treat the cells respectively. The role of AMPK in the regulation of 
Nrf2 expression in C2C12 cells and its mechanism were observed. 
Methods Cell experiments were performed on C2C12 cells of skeletal muscle of mice, and AMPK 
activator AICAR and AMPK inhibitor Compound C were used to intervene. The fluorescence intensity 
of C2C12 cells in each group was qualitatively detected by fluorescence inverted microscope, and the 
ROS level of C2C12 cells in each group was detected by fluorescence colorimetry. Results the ROS 
level of each group was significantly higher than that of the control group. RT-PCR assay was used to 
detect the antioxidant enzyme mRNA level of C2C12 cells in each group. Western Blot assay was used 
to detect the expression of AMPK alpha, pAMPK alpha, Nrf2, pNrf2 and antioxidant enzyme protein in 
C2C12 cells of each group. 
Results (1) compared with the control group, the pAMPK alpha /AMPK alpha ratio of C2C12 cells in 
the agonist group increased significantly, the expression of pNrf2 protein in the cells increased 
significantly, and the expression of NQO1mRNA, HO-1mRNA and GSR mRNA increased significantly, 
and the cells SOD1, GCLM, NQO1, HO-1, pNrf2, and protein were significantly increased. Low. (2) 
compared with the control group, the levels of NQO1mRNA, HO-1mRNA, CATmRNA, SOD1mRNA, 
Gpx-1mRNA and GCLc mRNA in the C2C12 cells of the inhibitor group decreased significantly, and 
the expression of NQO1 and GCLM proteins in the cells decreased significantly, and the ROS level of 
the cells increased significantly. 
Conclusions  (1) the activation of AMPK by AICAR activates the increase of Nrf2 activation in 
skeletal muscle C2C12 cells, and then increases the expression of mRNA and protein (SOD1, GCLM, 
NQO1, NQO1, GSR) in the downstream of Nrf2 (NQO1, HO-1, GSR), and significantly reduces the 
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intracellular level.(2) the inhibition of AMPK by Compound C significantly decreased the mRNA 
expression of C2C12 cells (NQO1, HO-1, CAT, SOD1, Gpx-1, GCLc) in skeletal muscle, and significantly 
decreased the expression of protein (NQO1 and GCLc). 
